RenovoRx Enrolls First Patient In UVM-Sponsored Pancreatic Cancer PRISM-TAMP Trial

RenovoRx announced enrollment of the first patient in PRISM-TAMP, an investigator-initiated trial titled “PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP.” The available article text identifies the University of… as the trial sponsor but cuts off before naming it; no trial results or additional enrollment details are provided.